An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancer
- 1 August 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (8) , 1299-1303
- https://doi.org/10.1016/0277-5379(88)90219-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Thyrocyte HLA class II expression and regulation in relation to thyroid autoimmunityActa Endocrinologica, 1987
- HLA class II induction in human islet cells by interferon-γ plus tumour necrosis factor or lymphotoxinNature, 1987
- TREATMENT OF MALIGNANT ENDOCRINE PANCREATIC TUMOURS WITH HUMAN LEUCOCYTE INTERFERONThe Lancet, 1986
- Thyroid Autoimmunity in Patients on Long Term Therapy with Leukocyte-Derived Interferon*Journal of Clinical Endocrinology & Metabolism, 1986
- The significance of supraclavicular fossa node recurrence after radical mastectomyCancer, 1986
- PRIMARY HYPOTHYROIDISM ASSOCIATED WITH INTERFERON THERAPY OF BREAST CANCERThe Lancet, 1985
- Recombinant DNA human interferon alpha 2 in advanced breast cancer: A phase 2 trialBritish Journal of Cancer, 1985
- Survival following local skin recurrence after mastectomyBritish Journal of Surgery, 1985
- ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITYThe Lancet, 1983
- Lectin-induced expression of DR antigen on human cultured follicular thyroid cellsNature, 1983